Dyadic International DYAI
NASDAQ DYAI
$0.69 -0.01 (-1.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dyadic International (DYAI) Profit After Tax (2018 - 2026)

Dyadic International (DYAI) posted Profit After Tax of -$2.0 million for Q1 2026, down 24.72% sequentially from -$1.6 million in Q4 2025, and up 3.6% YoY from -$1.9 million in Q1 2025.

Dyadic International (DYAI) Profit After Tax (2018 - 2026) Analysis & Trends

Dyadic International has reported Profit After Tax for 9 years, with the latest figure at -$2.0 million in Q1 2026.

  • Quarterly Profit After Tax rose 3.6% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.3 million (down 25.13% YoY) and the FY2025 annual result came in at -$7.4 million, down 26.78% from the prior year.
  • Profit After Tax fell to -$2.0 million in Q1 2026 per DYAI's latest filing, from -$1.6 million in the prior quarter.
  • Over five years, Profit After Tax peaked at -$203460.0 in Q3 2024 and troughed at -$3.3 million in Q2 2022.
  • A 5-year average of -$1.9 million and a median of -$2.0 million in 2025 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2024 and 2025: Profit After Tax surged 87.4% in 2024, then tumbled 871.2% in 2025.
  • Over 5 years, Profit After Tax stood at -$2.1 million in 2022, then increased by 3.48% to -$2.1 million in 2023, then grew by 25.14% to -$1.6 million in 2024, then dropped by 1.06% to -$1.6 million in 2025, then decreased by 24.72% to -$2.0 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$2.0 million, -$1.6 million, and -$2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Dyadic International 19.98 Mn 19.98 Mn - -1.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.95 Mn
Dec 31, 2025 -1.57 Mn
Sep 30, 2025 -1.98 Mn
Jun 30, 2025 -1.79 Mn
Mar 31, 2025 -2.03 Mn
Dec 31, 2024 -1.55 Mn
Sep 30, 2024 -203,460.00
Jun 30, 2024 -2.05 Mn
Mar 31, 2024 -2.01 Mn
Dec 31, 2023 -2.07 Mn
Sep 30, 2023 -1.61 Mn
Jun 30, 2023 -2.15 Mn
Mar 31, 2023 -956,444.00
Dec 31, 2022 -2.15 Mn
Sep 30, 2022 -1.81 Mn
Jun 30, 2022 -3.29 Mn
Mar 31, 2022 -2.49 Mn
Dec 31, 2021 -4.21 Mn
Sep 30, 2021 -1.72 Mn
Jun 30, 2021 -3.85 Mn